» Authors » Alexander Reichart

Alexander Reichart

Explore the profile of Alexander Reichart including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 1302
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Goetze T, Reichart A, Bankstahl U, Pauligk C, Loose M, Kraus T, et al.
Ann Surg Oncol . 2024 Mar; 31(6):4073-4083. PMID: 38459418
Background: Although addition of adjuvant chemotherapy is the current standard, the prognosis of pancreatic cancers still remains poor. The NEPAFOX trial evaluated perioperative treatment with FOLFIRINOX in resectable pancreatic cancer....
2.
Ramsower C, Rosenthal A, Robetorye R, Mwangi R, Maurer M, Villa D, et al.
Br J Haematol . 2023 Oct; 204(1):160-170. PMID: 37881141
Mantle cell lymphoma (MCL) is clinically and biologically heterogeneous. While various prognostic features have been proposed, none currently impact therapy selection, particularly in older patients, for whom treatment is primarily...
3.
Jaramillo S, Le Cornet L, Kratzmann M, Krisam J, Gorner M, Hanel M, et al.
Trials . 2023 Sep; 24(1):591. PMID: 37715270
Background: About 50% of older patients with acute myeloid leukemia (AML) fail to attain complete remission (CR) following cytarabine plus anthracycline-based induction therapy. Salvage chemotherapy regimens are based on high-dose...
4.
Al-Batran S, Hofheinz R, Reichart A, Pauligk C, Schonherr C, Schlag R, et al.
Int J Cancer . 2020 Oct; 148(6):1478-1488. PMID: 33038277
Few data exist on health-related quality of life (QoL) in patients with metastatic pancreatic cancer (mPC) receiving first-line chemotherapy (Awad L ZE, Mesbah M Boston, MA. Applying survival data methodology...
5.
Al-Batran S, Homann N, Pauligk C, Goetze T, Meiler J, Kasper S, et al.
Lancet . 2019 Apr; 393(10184):1948-1957. PMID: 30982686
Background: Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the docetaxel-based triplet FLOT (fluorouracil plus leucovorin, oxaliplatin and...
6.
Schmalenberg H, Al-Batran S, Pauligk C, Zander T, Reichart A, Lindig U, et al.
J Cancer Res Clin Oncol . 2017 Dec; 144(3):559-569. PMID: 29285668
Introduction: This is a single-arm study (NCT01956149) to determine the prolonged (≥ 4 months) disease control rate with cabazitaxel administered in second-(or later) setting for patients with advanced or metastatic...
7.
Al-Batran S, Hofheinz R, Pauligk C, Kopp H, Haag G, Luley K, et al.
Lancet Oncol . 2016 Oct; 17(12):1697-1708. PMID: 27776843
Background: Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma, but has not yet been evaluated in the context of resectable patients. Here we report findings from the...